Skip to main content

PHAR · Pharming Group N.V. · Short Volume

Track PHAR — free
$10.78 -0.43 (-3.80%) At close · Sep 14
Market Cap
$793.42M
Shares
70.78M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-09-14 3,414 0 5,229 65.3%
2026-09-11 16,741 0 22,546 74.3%
2026-09-10 903 0 6,587 13.7%
2026-09-09 2,463 0 3,330 74.0%
2026-09-08 1,193 0 1,401 85.2%
2026-09-04 1,034 0 1,231 84.0%
2026-09-03 1,882 0 2,263 83.1%
2026-09-02 2,435 0 3,286 74.1%
2026-09-01 1,678 0 8,974 18.7%
2026-08-31 1,272 0 4,750 26.8%
2026-08-28 2,245 0 4,158 54.0%
2026-08-27 2,580 0 3,409 75.7%
2026-08-26 4,512 0 7,657 58.9%
2026-08-25 2,743 0 3,597 76.3%
2026-08-24 6,404 0 10,560 60.6%
2026-08-21 971 0 3,083 31.5%
2026-08-20 4,853 29 7,794 62.3%
2026-08-19 7,092 0 8,727 81.3%
2026-08-18 3,923 0 6,177 63.5%
2026-08-17 3,506 0 7,734 45.3%
2026-08-14 10,136 0 13,110 77.3%
2026-08-13 13,925 0 19,593 71.1%
2026-08-12 7,992 701 11,921 67.0%
2026-08-11 23,405 0 26,824 87.3%
2026-08-10 22,321 0 28,039 79.6%
2026-08-07 221 0 4,394 5.0%
2026-08-06 2,072 0 2,709 76.5%
2026-08-05 1,202 0 3,401 35.3%
2026-08-04 2,955 98 3,772 78.4%
2026-08-03 2,260 100 6,652 34.0%
2026-07-31 1,876 208 13,327 14.1%
2026-07-30 8,909 0 12,932 68.9%
2026-07-29 1,804 0 2,149 83.9%
2026-07-28 1,862 0 2,621 71.0%
2026-07-27 4,487 0 4,657 96.4%
2026-07-24 2,560 0 3,596 71.2%
2026-07-23 919 0 986 93.2%
2026-07-22 647 0 913 70.9%
2026-07-21 1,068 0 2,122 50.3%
2026-07-20 1,196 0 1,886 63.4%
2026-07-17 203 0 5,616 3.6%
2026-07-16 167 0 977 17.1%
2026-07-15 164 0 1,756 9.3%
2026-07-14 1,662 0 1,984 83.8%
2026-07-13 1,501 0 3,485 43.1%
2026-07-10 5,441 440 10,053 54.1%
2026-07-09 183 0 1,901 9.6%
2026-07-08 2,521 0 6,314 39.9%
2026-07-07 960 0 2,164 44.3%
2026-07-06 2,415 5 7,350 32.9%
Showing 1–50 of 63 days
Key facts CIK 1828316 CUSIP 71716E105 13F (30d) 4 filings 3 filers Visit website Investor relations